We identified a robust decrease in PCK1 expression in the livers of MAFLD mice and patients with NAFLD/NASH, causing severe hepatic steatosis and confirming that disordered hepatic gluconeogenesis affects lipid homeostasis. The gene discussed is PCK1; the disease is metabolic dysfunction-associated steatohepatitis.